Anteris Technologies Global Corp. Common Stock (NASDAQ:AVR) — Market Cap & Net Worth
Market Cap & Net Worth: Anteris Technologies Global Corp. Common Stock (AVR)
Anteris Technologies Global Corp. Common Stock (NASDAQ:AVR) has a market capitalization of $749.46 Million ($749.46 Million) as of September 26, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #10281 globally and #2742 in its home market, demonstrating a -8.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Anteris Technologies Global Corp. Common Stock's stock price $7.69 by its total outstanding shares 97458474 (97.46 Million). Also see AVR asset base for a full breakdown of the balance sheet.
Anteris Technologies Global Corp. Common Stock Market Cap History: 2024 to 2026
Anteris Technologies Global Corp. Common Stock's market capitalization history from 2024 to 2026. Data shows growth from $543.82 Million to $749.46 Million (19.46% CAGR). Also see AVR cash generation efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
Anteris Technologies Global Corp. Common Stock is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.64 Trillion | 0.03% | #286 of 976 |
|
NASDAQ Composite
IXIC
|
$42.21 Trillion | 0.00% | #1063 of 3165 |
Weight: Anteris Technologies Global Corp. Common Stock's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Anteris Technologies Global Corp. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Anteris Technologies Global Corp. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Anteris Technologies Global Corp. Common for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
254.22x
Anteris Technologies Global Corp. Common Stock's market cap is 254.22 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $543.82 Million | $2.70 Million | -$76.29 Million | 201.19x | N/A |
| 2025 | $486.32 Million | $1.91 Million | -$94.14 Million | 254.22x | N/A |
Competitor Companies of AVR by Market Capitalization
Companies near Anteris Technologies Global Corp. Common Stock in the global market cap rankings as of September 26, 2026. Review Anteris Technologies Global Corp. Common (AVR) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Anteris Technologies Global Corp. Common Stock by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #129 globally with a market cap of $176.13 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Stryker Corporation (NYSE:SYK): Ranked #240 globally with a market cap of $104.47 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #129 | Abbott Laboratories | NYSE:ABT | $176.13 Billion | $101.29 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $88.64 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #240 | Stryker Corporation | NYSE:SYK | $104.47 Billion | $272.36 |
Anteris Technologies Global Corp. Common Stock Historical Marketcap From 2024 to 2026
Between 2024 and today, Anteris Technologies Global Corp. Common Stock's market cap moved from $543.82 Million to $ 749.46 Million, with a yearly change of 19.46%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $749.46 Million | +54.11% |
| 2025 | $486.32 Million | -10.57% |
| 2024 | $543.82 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 26th, 2026 the market cap of Anteris Technologies Global Corp. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $749.46 Million USD |
| MoneyControl | $749.46 Million USD |
| MarketWatch | $749.46 Million USD |
| marketcap.company | $749.46 Million USD |
| Reuters | $749.46 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Anteris Technologies Global Corp. Common Stock
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT ant… Read more